" /> Eicosapentaenoate Docosapentaenate w3 Docosahexaenoate/Fatty acids.C14-C22 risk:Imp:Pt:Bld:Ord: - CISMeF





Preferred Label : Eicosapentaenoate Docosapentaenate w3 Docosahexaenoate/Fatty acids.C14-C22 risk:Imp:Pt:Bld:Ord:;

LOINC status : ACTIVE;

LOINC display name : EPA DPA DHA/Fatty acids.C14-C22 risk Ql (Bld) [Interp];

LOINC long common name : Eicosapentaenoate (C20:5w3) Docosapentaenate (C22:5w3) Docosahexaenoate (C22:6w3)/Fatty acids.C14-C22 risk [Interpretation] in Blood Qualitative;

LOINC short name : EPA DPA DHA/FA.C14-C22 risk Bld Imp;

LOINC description : Risk of sudden death due to cardiovascular disease based on the % of EPA DPA DHA out of total fatty acids C14-C22. This term was created for, but is not limited in use to, the submitter's OmegaCheck test performed at the Cleveland Heart Lab. Note that a similar LOINC exists for the risk of cardiovascular disease based on % of EPA DHA out of total fatty acids C14-C24 [LOINC: 88999-8].;

Details


You can consult :


Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.